John Rim's guest appearances

John Rim

The Korea Society

Judy Joo

Haemin Sunim

Todd Henry

Andrew Friedman

Hooni Kim

Scott Snyder

John Cho

Scott Walker

Walter Russell Mead

Charlotte Cho

Eric Nam

Lee Isaac Chung

John Park

David Yoon

Krys Lee

OwlTail

Samsung BioLogics

July 21, 2021 - Join us for a conversation between Mr. John Rim, President and CEO of Samsung Biologics, and Tom Byrne, the President and CEO of The Korea Society. In this second episode of the ‘President’s Interview Series,’ President Rim will discuss his extensive career and senior leadership roles in the biopharmaceutical industry, as well as his current role as the head of Samsung Biologics. With over 30 years of experience, President Rim played a key leadership role in facilitating the growth of Samsung Biologics into one of the world’s largest contract development and manufacturing organization (CDMO). This interview will also provide an opportunity to learn more about the role of Samsung Biologics in the global biopharmaceutical industry including the recent agreement with the US biotech firm, Moderna, for fill-finish manufacturing of its path breaking mRNA COVID-19 Vaccine. This program was recorded at Samsung Biologics headquarters in Songdo, Incheon when President Byrne recently visited South Korea. For more information, please visit the link below: https://www.koreasociety.org/policy-and-corporate-programs/item/1509-talking-covid-19-vaccine-cooperation-with-president-john-rim

July 21, 2021 - Join us for a conversation between Mr. John Rim, President and CEO of Samsung Biologics, and Tom Byrne, the President and CEO of The Korea Society. In this second episode of the ‘<a href="https://www.koreasociety.org/policy-and-corporate-programs/president-s-interview-series" rel="noopener nofollow" target="_blank">President’s Interview Series</a>,’ President Rim will discuss his extensive career and senior leadership roles in the biopharmaceutical industry, as well as his current role as the head of Samsung Biologics. With over 30 years of experience, President Rim played a key leadership role in facilitating the growth of Samsung Biologics into one of the world’s largest contract development and manufacturing organization (CDMO). This interview will also provide an opportunity to learn more about the role of Samsung Biologics in the global biopharmaceutical industry including the recent agreement with the US biotech firm, Moderna, for fill-finish manufacturing of its path breaking mRNA COVID-19 Vaccine. This program was recorded at Samsung Biologics headquarters in Songdo, Incheon when President Byrne recently visited South Korea. For more information, please visit the link below: <a href="https://www.koreasociety.org/policy-and-corporate-programs/item/1509-talking-covid-19-vaccine-cooperation-with-president-john-rim" rel="noopener nofollow" target="_blank">https://www.koreasociety.org/policy-and-corporate-programs/item/1509-talking-covid-19-vaccine-cooperation-with-president-john-rim</a>

Talking COVID-19 Vaccine Cooperation with John Rim, Samsung Biologics President & CEO